Tenaya Therapeutics annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Tenaya Therapeutics Capital Expenditures (CapEx) Growth & History (TNYA)
Tenaya Therapeutics's capital expenditures (capex) was $618,000 for fiscal 2025.
View full Tenaya Therapeutics company overviewTenaya Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $618,000 | −$407,000 | −39.71% |
| 2024 | 2024-12-31 | $1.0M | −$214,000 | −17.27% |
| 2023 | 2023-12-31 | $1.2M | −$19.4M | −93.99% |
| 2022 | 2022-12-31 | $20.6M | −$4.5M | −17.88% |
| 2021 | 2021-12-31 | $25.1M | $15.4M | +157.31% |
| 2020 | 2020-12-31 | $9.8M | — | — |
Tenaya Therapeutics quarterly capital expenditures (capex)
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $159,000 | $17,000 | +11.97% |
| Q1 2026 | 2026-03-31 | $11,000 | −$372,000 | −97.13% |
| Q4 2025 | 2025-12-31 | $67,000 | −$137,000 | −67.16% |
| Q3 2025 | 2025-09-30 | $26,000 | −$158,000 | −85.87% |
| Q2 2025 | 2025-06-30 | $142,000 | $69,000 | +94.52% |
| Q1 2025 | 2025-03-31 | $383,000 | −$181,000 | −32.09% |
| Q4 2024 | 2024-12-31 | $204,000 | −$190,000 | −48.22% |
| Q3 2024 | 2024-09-30 | $184,000 | $176,000 | +2200.00% |
| Q2 2024 | 2024-06-30 | $73,000 | −$135,000 | −64.90% |
| Q1 2024 | 2024-03-31 | $564,000 | −$65,000 | −10.33% |
| Q4 2023 | 2023-12-31 | $394,000 | −$401,000 | −50.44% |
| Q3 2023 | 2023-09-30 | $8,000 | −$4.1M | −99.80% |
| Q2 2023 | 2023-06-30 | $208,000 | −$7.0M | −97.10% |
| Q1 2023 | 2023-03-31 | $629,000 | −$8.0M | −92.68% |
| Q4 2022 | 2022-12-31 | $795,000 | −$11.8M | −93.67% |
| Q3 2022 | 2022-09-30 | $4.1M | −$944,000 | −18.85% |
| Q2 2022 | 2022-06-30 | $7.2M | $3.9M | +121.76% |
| Q1 2022 | 2022-03-31 | $8.6M | $4.3M | +98.82% |
| Q4 2021 | 2021-12-31 | $12.6M | — | — |
| Q3 2021 | 2021-09-30 | $5.0M | $4.8M | +2991.36% |
| Q2 2021 | 2021-06-30 | $3.2M | — | — |
| Q1 2021 | 2021-03-31 | $4.3M | — | — |
| Q3 2020 | 2020-09-30 | $162,000 | — | — |
Tenaya Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, Tenaya Therapeutics's capital expenditures (capex) decreased from $9.8M to $618,000, a change of −$9.1M. The latest reported quarter, Q2 2026, shows $159,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tenaya Therapeutics source filings ↗